Johnson & Johnson (JNJ) updated its FY13 earnings guidance on Tuesday. The company provided EPS guidance of $5.35-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.50.

Several analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a hold rating on shares of Johnson & Johnson in a research note to investors on Wednesday, January 16th. They now have a $79.00 price target on the stock, up previously from $75.00. On a related note, analysts at JPMorgan Chase reiterated an overweight rating on shares of Johnson & Johnson in a research note to investors on Tuesday, January 15th. They now have a $77.00 price target on the stock. Finally, analysts at UBS AG raised their price target on shares of Johnson & Johnson from $76.00 to $78.00 in a research note to investors on Friday, January 11th. They now have a buy rating on the stock.

Eleven investment analysts have rated the stock with a buy rating, four have given an overweight rating, nine have assigned a hold rating, and two have assigned a sell rating to the company. The stock presently has a consensus rating of overweight and a consensus price target of $77.81.

Johnson & Johnson (JNJ) opened at 73.23 on Tuesday. Johnson & Johnson (JNJ) has a 52-week low of $61.71 and a 52-week high of $73.23. The stock’s 50-day moving average is currently $71.. The company has a market cap of $202.9 billion and a price-to-earnings ratio of 23.99.

Johnson & Johnson last released its earnings data on Tuesday, January 22nd. The company reported $1.19 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.17 by $0.02. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.67 billion. During the same quarter in 2012, the company posted $1.13 earnings per share. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Johnson & Johnson has set its FY13 guidance at $5.35-5.45 EPS. Analysts expect that Johnson & Johnson (JNJ) will post $5.09 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 12th. Investors of record on Tuesday, February 26th will be given a dividend of $0.61 per share. This represents a $2.44 dividend on an annualized basis and a yield of 3.33%. The ex-dividend date of this dividend is Friday, February 22nd.

Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.